MJARF Mjardin (MJARF)

[BlueGreenPower]

Nice video close-ups of MSIKU Gelatti and White Wedding flower, grown at Mjardin's JV facility in Nova Scotia.

MSIKU getting some great reviews on Reddit...

https://www.reddit.com/r/TheOCS/comments/i7ag8x/cannabis_review_labs_msiku/

New investor presentation...

http://s23.q4cdn.com/330466466/files/doc_presentations/2020/11/MJAR-Deck_Nov22.pdf

Agree with you noodle. Mjardin has gone way past the bottom... imho glta

[noodle]

Looks like the bottom is in here, time to MOVE !!!UP

[noodle]

I needed 4 recent post to be considered for a moderator position.

[noodle]

I needed 4 recent post to be considered for a moderator position.

[noodle]

High risk but possible great return.

[noodle]

low float

[noodle]

I continue to add.

[conix]

MJardin Group Announces Third Quarter 2020 Financial Results

November 05, 2020 08:00 ET | Source: MJardin Group, Inc.

Continued stabilization of the business with steadfast focus on cost management, and production maximization to drive revenue and margin growth
Continued revenue growth expected in Q4 2020

DENVER and TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for its third quarter ended September 30, 2020. All amounts are expressed in Canadian dollars unless otherwise indicated.

Q3 Highlights:

The Company has been able to grow a new fifth strain testing at 24% THC on behalf of Robes at its WILL facility (“WILL”);
All harvests out of the WILL and GRO facilities (“GRO”) have passed HC microbial testing without the use of irradiation treatment;
Revenue amounted to $4.8 million;
Adjusted EBITDA loss of $1.4 million;
Net income of $7.2 million;
AtlantiCann Medical Inc. (“AMI”) joint venture contributed $3.1 million to earnings, an increase of approximately 140% from the prior quarter, as shown on net earnings from equity investment line in the financial statements;
Completed first wholesale transaction following completion of construction at all Ontario facilities;
Completed construction and licensing of final two flower rooms at the Company’s WILL cultivation facility located in Brampton, Ontario;
Entered into master service agreement with the Ontario Cannabis Store (“OCS”) for cannabis cultivated at WILL;
138% increase in quarter-over-quarter flower production at the Company’s GRO cultivation facility located in Dunnville, Ontario;
In anticipation of launching retail products in Q4 2020, the Company has transitioned away from previously announced wholesale agreements.

“We continue to work diligently to complete our asset optimization initiatives to drive continued revenue growth objectives. Our operational and financial performance during the quarter continues to validate our team’s efforts as we report a third consecutive quarter of stable operations,” commented Pat Witcher, CEO of MJardin. “We continue to explore strategic opportunities with the potential to complement our organic growth profile while ultimately creating shareholder value. We remain confident in the prospects for our business, and look forward to sharing our success with our shareholders as we execute our turnaround plan.”

[conix]

Tough to get excited about cannabis stocks after their recent move up. When Biden wins, we may get another pop.

[conix]

MJardin Group Announces Master Service Agreement with the Ontario Cannabis Store

MJardin premium cultivated product now available to Ontario consumers under the Flint and Embers brand

DENVER, Colorado, and TORONTO, Canada, October 7, 2020 -- MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced that it has received approval, and executed a master service agreement (the “MSA”) with the Ontario Cannabis Store (the “OCS”), for the sale of its premium, high quality cannabis in the Ontario market, under the Flint and Embers brand.

The OCS approval and MSA, which immediately enable MJardin to make its product available to consumers in Ontario, is an important step in MJardin’s evolution from a pure play cultivator to a consumer-centric company, servicing the needs of retail consumers, in-line with the 2020 strategic plan. As a result, the Company expects increased revenues from same flower production given the higher realized price per gram at the retail sales level, while getting market recognition and consumer brand awareness under the Flint and Embers banner.

[GreenIvest544]

Hope you bought into them! They have something special, top shelf products and the whole seed to sale going for them. Did you see their latest news release? Claiming 500% rev jump! They are going places!

As far as Mjardin, I bought a small handful of shares in the high .03’s and going to wait it out, kinda see what they do in the next few weeks!

[noodle]

Thanks for DBCCF looks good around!!!

[noodle]

I own around 150k here, I believe that is enough. Went with tgiff!!!

[GreenIvest544]

Hey noodle, I’ve been pondering the same thing. I bought DBCCF when it dipped into the .04’s...and I wanted MJARF then, but I’ve been pondering both(TGIFF and MJARF) What did you decide on?

It was my hopes that MJARF would take advantage of the HB1090 and purchase the assets in CO. Either way, can’t believe it dipped into the .03’s!

[noodle]

My biggest question is whether to buy more mjarf this cheaply or buy T G I F F @ .04 ??? I own enough here, going for the other.

[noodle]

The stock looks ready for a move up.

[noodle]

Super under the radar !!!!

[noodle]

Grabbed a ton of cheap shares today, all under .06, to me, that is a great deal. Time will tell!!!

[make it happen]

Yes been great op on the low imo

[DailyMJObserver]

MJardin Group Announces Amendment to its Borrowing Obligations


Read more here...

[conix]

MJardin’s Atlantic Canada Cultivation & Extraction Facility Receives Sales Licence

Phase 2 Expansion to be complete January 2020

January 08, 2020 08:00 ET | Source: MJardin Group, Inc.

TORONTO and DENVER, Jan. 08, 2020 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, is pleased to announce its AtlantiCann Medical Inc. (“AMI”) facility has been awarded a sales licence from Health Canada. AMI is a joint venture corporation consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).

The licence comes just weeks before phase 2 construction is set to be complete adding 20,000 square feet to the original footprint making the expanded facility 68,000 square feet with a total of 6,300 kg/year of production capacity.

“This is a significant day and great achievement for the Mi’kmaq of Nova Scotia and our partners as we receive this licence and can begin to sell to the Canadian retail market,” said Chief Terrance Paul, Co-Chair of the Assembly of Nova Scotia Mi’kmaw Chiefs. “We have expanded our footprint and production capacity and can now realize the full potential of our joint venture.”

“Our team is very proud of this important milestone and it means great things for our partnership,” said Pat Witcher, Chief Executive Officer of MJardin Group. “We are thrilled to bring our high-quality product to market, and we are confident that Canadian consumers will agree. We also look forward to serving the international market in 2020 from the AMI facility with our European distribution partners.”

On September 9, 2019, MJardin announced that the AMI facility has secured a supply contract with Franchise Cannabis Corp. subsidiary, ACA Muller for 2,250 kg of high THC (>20%) medical cannabis to serve the German market. AMI expects to receive EU GMP certification in Q4 2020.

[noodle]

ok I will moderate

[noodle]

Anyone else lurking???

[noodle]

Good morning Mjarf fans!!!

[noodle]

I am here waiting for my price, alone again!!! I hope it works out better than the last time!!! LOL

[Golden Cross]

News - MJardin Receives Full Purchase Price from Joint Venture Partner and Begins Phase 2 Development at its Largest Cultivation Facility
Email Print Friendly Share
October 04, 2019 08:00 ET | Source: MJardin Group, Inc.
TORONTO and DENVER, Oct. 04, 2019 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that subsequent to its recently announced non-binding Letter of Intent (“LOI”) with Peguis First Nation (“Peguis”) in connection with its Warman cultivation facility located in Winnipeg, Manitoba, the Company has entered into an agreement whereby Peguis has agreed to pay the full amount of the purchase price in advance of the closing of the transaction pursuant to a promissory note.

MJardin has received the C$11 million payment from Peguis, which immediately allows the Company to commence Phase 2 construction and expedite the path to full production of the Warman facility.

On August 28, 2019, MJardin announced the signing of a non-binding LOI with Peguis concerning a joint venture (“JV”) in connection with the operation and ownership of its Warman cultivation facility. Under the terms of the agreement, Peguis (51%) will purchase existing land and buildings from MJardin (49%) for C$11 million and execute a concurrent long-term lease back to the JV. Peguis will additionally fund the capital expenditures required to complete Phase 2 of the facility for approximately C$20.5 million.

Design plans for the Warman facility were released last month and include a hybrid facility encompassing indoor and greenhouse production capacity, along with full EU GMP certified extraction, processing and packaging capabilities. Phase 2 of the build-out will see the facility reach production capacity of approximately 4,500 kg of high-quality dried flower and 800 litres of bulk oil for use in refined products by Q2 2020.

About MJardin Group
MJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com.

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information
This news release contains forward-looking information based on current expectations. Statements about, among other things, future developments and the business and operations of MJardin, our production capacity, our production results, trading of MJardin’s shares on the OTCQX Best Market, the receipt of any pending regulatory approvals or licenses, the growth of our global footprint and our intentions to leverage our scale for continued organic growth and to pursue strategic investments are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such factors include, but are not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or investment in. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that the proposed acquisition will occur and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. MJardin assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

INVESTOR CONTACT:
Ali Mahdavi Pat Witcher
Capital Markets & Investor Relations Chief Operating Officer
416-962-3300 720-613-4019
[e-mail] ?[e-mail]

[conix]

MJARF Chart

[oxnous]

Is anyone still following MJARDF? No posting means little interest.

[Billy055]

http://seekingalpha.com/article/4264418-mjardin-group-mjarf-investor-presentation-slideshow?dr=1

Mar-Dean or, perhaps, EM-Har'Dean

[Billy055]

I know I am excited about the chance to add shares.
Of course I'm worried about how many more shares there may be in the next months or years (there are about 80,000,000 right now) but I see this as the #1 most exciting stock of all the farming stocks right now.

Also I expect they may turn into an MSO in the next 12 or 15 months.

My average price is $1.45 right now...it seem some "barfers" knew about it before it even was available in the USA!
Actually I looked for this ticker back when I added it to my stocks and now suddenly and retroactively {POOF} here it is.....created BEFORE it was even out yet!!!

Anyway it will be over 2 weeks before I will have any cash but I, for one, will be adding to my shares assuming it's not much higher than my average of $1.45.....

[Mr Cute]

Couldn't agree more. About time!

[Benji $x]

Reversal way over sold

[oxnous]

MJARF chart that works. lol

[upper11]

https://www.stockcharts.com/h-sc/ui

[Raphael De La Ghetto]

Barf!